RBC Starts Cepheid (CPHD) at Outperform
More News related to CPHD
- Cepheid to Webcast Upcoming Financial Presentations
- Cepheid (CPHD) Tops Q3 EPS Views; Guides
- Cepheid Reports 2009 Third Quarter Results
- Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
- Unusual 11 Mid-Day Movers 10/14: CHIO, ACPW, JADE, CNO Higher; CXM, HILL, UCBH, UPI Lower
More News related to New Coverage
- Piper Jaffray Initiates Coverage on Hain Celestial Group (HAIN) with a Neutral; Upside Potential is Limited
- Piper Jaffray Initiates Coverage on Green Mountain Coffee (GMCR) with an Overweight; Several Potential Catalysts
- Piper Jaffray Initiates Coverage on B&G Foods (BGS) with a Neutral; Stock Reflects Fair Valuation
- Piper Jaffray Initiates Coverage on Del Monte Foods (DLM) with a Neutral
- Longbow Starts KR, WFMI at Buy, SWY, SVU at Neutral
RBC Capital initiates coverage on Cepheid (Nasdaq: CPHD) with an Outperform rating.
Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for genetic testing in the clinical molecular diagnostic, industrial, and biothreat markets.
Related Categories
New CoverageStocks Mentioned
-0.53Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
